Compare NRIX & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRIX | AGM |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2020 | N/A |
| Metric | NRIX | AGM |
|---|---|---|
| Price | $19.17 | $177.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | $29.08 | ★ $219.00 |
| AVG Volume (30 Days) | ★ 1.5M | 88.5K |
| Earning Date | 01-27-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | N/A | ★ 12.85 |
| EPS | N/A | ★ 17.55 |
| Revenue | $83,687,000.00 | ★ $377,946,000.00 |
| Revenue This Year | $59.40 | $14.80 |
| Revenue Next Year | N/A | $9.98 |
| P/E Ratio | ★ N/A | $10.05 |
| Revenue Growth | ★ 48.32 | 8.81 |
| 52 Week Low | $8.18 | $155.00 |
| 52 Week High | $22.50 | $212.24 |
| Indicator | NRIX | AGM |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 53.99 |
| Support Level | $16.98 | $171.27 |
| Resistance Level | $19.92 | $180.50 |
| Average True Range (ATR) | 0.90 | 3.78 |
| MACD | -0.22 | -0.51 |
| Stochastic Oscillator | 72.82 | 67.51 |
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.